Experienced in Prader-Willi Syndrome

Bruno Guerci

Nancy, FR 
Experienced in Prader-Willi Syndrome
Nancy, FR 
OverviewLocationsClinical Research

Overview

Bruno Guerci practices in Nancy, France. Mr. Guerci is rated as an Experienced expert by MediFind in the treatment of Prader-Willi Syndrome. His top areas of expertise are Type 2 Diabetes (T2D), Low Blood Sugar, Type 1 Diabetes (T1D), Diabetic Ketoacidosis, and Islet Cell Transplantation.

His clinical research consists of co-authoring 127 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Prader-Willi Syndrome.

Gender
Male

Locations

Nancy, 54500, France
Other Locations
Vandoeuvre-les-nancy, 54500, France
Alsace
Strasbourg, France
Rennes, 35200, France
Poitiers, 86021, France
Toul, 54201, France
Grenoble, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

The Effect of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Patients With Type 2 Diabetes (SURPASS-CVOT)
The Effect of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Patients With Type 2 Diabetes (SURPASS-CVOT)
Enrollment Status: Completed
Publish Date: August 24, 2025
Intervention Type: Drug
Study Drugs: Tirzepatide, Dulaglutide
Study Phase: Phase 3
Health Economic Analysis of Islet Cell Transplantation for Patients With Severe Forms of Brittle Type 1 Diabetes
Health Economic Analysis of Islet Cell Transplantation for Patients With Severe Forms of Brittle Type 1 Diabetes
Enrollment Status: Unknown
Publish Date: June 24, 2022
Intervention Type: Drug, Procedure
Study Drug: Best Medical Care
Study Phase: Phase 3
Dulaglutide and Insulin MicrosecretiON in Type 1 Diabetes : A Randomized Double-blind Placebo-controlled Trial
Dulaglutide and Insulin MicrosecretiON in Type 1 Diabetes : A Randomized Double-blind Placebo-controlled Trial
Enrollment Status: Completed
Publish Date: July 08, 2021
Intervention Type: Drug
Study Drug: Dulaglutide
Study Phase: Phase 2
Validation of a Predictive Risk Equation for Type 2 Diabetes in Children With Diabetes to Achieve a Predictive Diagnostic Biochip for the Early Detection of Individuals at Risk in Families.
Validation of a Predictive Risk Equation for Type 2 Diabetes in Children With Diabetes to Achieve a Predictive Diagnostic Biochip for the Early Detection of Individuals at Risk in Families.
Enrollment Status: Completed
Publish Date: May 11, 2021
Intervention Type: Other
Study Phase: Not Applicable
To Assess Whether Type 1 Diabetic Patients Treated With M D I and in Poor Metabolic Control Can Improve Using the Paradigm® Real Time System Compared to Self-Monitoring Blood Glucose and Continuous Subcutaneous Insulin Infusion
To Assess Whether Type 1 Diabetic Patients Treated With M D I and in Poor Metabolic Control Can Improve Using the Paradigm® Real Time System Compared to Self-Monitoring Blood Glucose and Continuous Subcutaneous Insulin Infusion
Enrollment Status: Completed
Publish Date: December 05, 2018
Intervention Type: Device
Study Phase: Not Applicable
Evaluation of the DIABEO System in Poorly Controlled DM1 or DM2 Patients Treated With a Basal-bolus Insulin Regimen
Evaluation of the DIABEO System in Poorly Controlled DM1 or DM2 Patients Treated With a Basal-bolus Insulin Regimen
Enrollment Status: Completed
Publish Date: August 21, 2018
Intervention Type: Device
Study Phase: Not Applicable
View 5 Less Clinical Trials

127 Total Publications

Management of patients with type 2 diabetes and MASLD: an overview and joint statement.
Management of patients with type 2 diabetes and MASLD: an overview and joint statement.
Journal: Diabetes & metabolism
Published: October 02, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Guerci's expertise for a condition
ConditionClose
View All 15 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile